Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132758) titled 'The efficacy and safety of high-dose dual therapy versus bismuth quadruple therapy in eradicating Helicobacter pylori in patients with type 2 diabetes: A randomized controlled non-inferiority study' on Sept. 18.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Hospital of Lanzhou University
Condition:
Helicobacter pylori infection
Intervention:
High-Dose Dual Therapy:Esomeprazole Magnesium Enteric-coated Tablets (40 mg, twice a day, taken before breakfast and dinner) Amoxicillin Capsules (1.0g, three times a day, taken before each meal).The treatment course is two weeks....